JP4815554B2 - 免疫中立性の絹繊維を基礎とする医療用具 - Google Patents
免疫中立性の絹繊維を基礎とする医療用具 Download PDFInfo
- Publication number
- JP4815554B2 JP4815554B2 JP2006507132A JP2006507132A JP4815554B2 JP 4815554 B2 JP4815554 B2 JP 4815554B2 JP 2006507132 A JP2006507132 A JP 2006507132A JP 2006507132 A JP2006507132 A JP 2006507132A JP 4815554 B2 JP4815554 B2 JP 4815554B2
- Authority
- JP
- Japan
- Prior art keywords
- fibers
- silk
- biocompatible
- yarns
- fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000835 fiber Substances 0.000 title claims description 394
- 230000007935 neutral effect Effects 0.000 title description 2
- 108010013296 Sericins Proteins 0.000 claims abstract description 87
- 230000002163 immunogen Effects 0.000 claims abstract description 4
- 239000004744 fabric Substances 0.000 claims description 154
- 108010022355 Fibroins Proteins 0.000 claims description 132
- 210000003041 ligament Anatomy 0.000 claims description 119
- 238000000034 method Methods 0.000 claims description 63
- 210000002435 tendon Anatomy 0.000 claims description 52
- 239000010410 layer Substances 0.000 claims description 35
- 241000255789 Bombyx mori Species 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 102000008186 Collagen Human genes 0.000 claims description 26
- 108010035532 Collagen Proteins 0.000 claims description 26
- 229920001436 collagen Polymers 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 230000010261 cell growth Effects 0.000 claims description 21
- 239000007943 implant Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 15
- 238000009940 knitting Methods 0.000 claims description 13
- 230000021164 cell adhesion Effects 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 210000000056 organ Anatomy 0.000 claims description 10
- 238000009941 weaving Methods 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 7
- 210000002808 connective tissue Anatomy 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 102000016942 Elastin Human genes 0.000 claims description 4
- 108010014258 Elastin Proteins 0.000 claims description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 229920002732 Polyanhydride Polymers 0.000 claims description 4
- 229920002549 elastin Polymers 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 239000004626 polylactic acid Substances 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000002356 single layer Substances 0.000 claims description 3
- 229920006237 degradable polymer Polymers 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 210000004872 soft tissue Anatomy 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 210000000779 thoracic wall Anatomy 0.000 claims 1
- 238000002513 implantation Methods 0.000 abstract description 27
- 210000004027 cell Anatomy 0.000 description 158
- 210000001519 tissue Anatomy 0.000 description 149
- 239000011159 matrix material Substances 0.000 description 104
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 80
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 48
- 230000006870 function Effects 0.000 description 47
- 239000000463 material Substances 0.000 description 46
- 238000000605 extraction Methods 0.000 description 41
- 238000001727 in vivo Methods 0.000 description 40
- 238000000338 in vitro Methods 0.000 description 29
- 230000000694 effects Effects 0.000 description 27
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical group NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 25
- 241000196324 Embryophyta Species 0.000 description 25
- 238000000576 coating method Methods 0.000 description 23
- 238000012986 modification Methods 0.000 description 23
- 230000004048 modification Effects 0.000 description 23
- 210000000988 bone and bone Anatomy 0.000 description 22
- 230000015556 catabolic process Effects 0.000 description 22
- 238000006731 degradation reaction Methods 0.000 description 22
- 230000012010 growth Effects 0.000 description 20
- 230000009467 reduction Effects 0.000 description 20
- 210000002950 fibroblast Anatomy 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- 239000011248 coating agent Substances 0.000 description 18
- 210000003127 knee Anatomy 0.000 description 18
- 238000010899 nucleation Methods 0.000 description 18
- 230000004069 differentiation Effects 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- 238000012545 processing Methods 0.000 description 17
- 238000013461 design Methods 0.000 description 16
- 230000000638 stimulation Effects 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 230000008439 repair process Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 206010019909 Hernia Diseases 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- TZSMWSKOPZEMAJ-UHFFFAOYSA-N bis[(2-methoxyphenyl)methyl] carbonate Chemical compound COC1=CC=CC=C1COC(=O)OCC1=CC=CC=C1OC TZSMWSKOPZEMAJ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 210000000629 knee joint Anatomy 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 102000001187 Collagen Type III Human genes 0.000 description 11
- 108010069502 Collagen Type III Proteins 0.000 description 11
- 239000012620 biological material Substances 0.000 description 11
- 239000004745 nonwoven fabric Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 108010064995 silkworm fibroin Proteins 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 10
- 210000000845 cartilage Anatomy 0.000 description 9
- 210000004439 collateral ligament Anatomy 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 210000003932 urinary bladder Anatomy 0.000 description 9
- 241000239290 Araneae Species 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 238000001878 scanning electron micrograph Methods 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 102000012422 Collagen Type I Human genes 0.000 description 7
- 108010022452 Collagen Type I Proteins 0.000 description 7
- 102000000503 Collagen Type II Human genes 0.000 description 7
- 108010041390 Collagen Type II Proteins 0.000 description 7
- 208000005422 Foreign-Body reaction Diseases 0.000 description 7
- 230000000735 allogeneic effect Effects 0.000 description 7
- 230000024245 cell differentiation Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000035882 stress Effects 0.000 description 7
- 230000025366 tissue development Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 210000003815 abdominal wall Anatomy 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 210000002967 posterior cruciate ligament Anatomy 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 229920001059 synthetic polymer Polymers 0.000 description 6
- 230000009772 tissue formation Effects 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000003278 mimic effect Effects 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 239000008149 soap solution Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- -1 yarns Substances 0.000 description 5
- 108010067306 Fibronectins Proteins 0.000 description 4
- 102000016359 Fibronectins Human genes 0.000 description 4
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 4
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920001872 Spider silk Polymers 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229920002988 biodegradable polymer Polymers 0.000 description 4
- 239000004621 biodegradable polymer Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 238000007918 intramuscular administration Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000009991 scouring Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 230000007838 tissue remodeling Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 239000002759 woven fabric Substances 0.000 description 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 3
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 229940112869 bone morphogenetic protein Drugs 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 108091092356 cellular DNA Proteins 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 210000004523 ligament cell Anatomy 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 210000003903 pelvic floor Anatomy 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000000611 regression analysis Methods 0.000 description 3
- 238000007634 remodeling Methods 0.000 description 3
- 210000000513 rotator cuff Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 210000001738 temporomandibular joint Anatomy 0.000 description 3
- 230000008467 tissue growth Effects 0.000 description 3
- 210000000626 ureter Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000557626 Corvus corax Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000014015 Growth Differentiation Factors Human genes 0.000 description 2
- 108010050777 Growth Differentiation Factors Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000238902 Nephila clavipes Species 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000004709 cell invasion Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000009986 fabric formation Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000011694 lewis rat Methods 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000036647 reaction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 210000005068 bladder tissue Anatomy 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002648 chondrogenic effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010073 coating (rubber) Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 229920006253 high performance fiber Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000005009 osteogenic cell Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000005428 wave function Effects 0.000 description 1
- 238000009816 wet lamination Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B21/00—Warp knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B21/14—Fabrics characterised by the incorporation by knitting, in one or more thread, fleece, or fabric layers, of reinforcing, binding, or decorative threads; Fabrics incorporating small auxiliary elements, e.g. for decorative purposes
- D04B21/16—Fabrics characterised by the incorporation by knitting, in one or more thread, fleece, or fabric layers, of reinforcing, binding, or decorative threads; Fabrics incorporating small auxiliary elements, e.g. for decorative purposes incorporating synthetic threads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
- D01F4/02—Monocomponent artificial filaments or the like of proteins; Manufacture thereof from fibroin
-
- D—TEXTILES; PAPER
- D02—YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
- D02G—CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
- D02G3/00—Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
- D02G3/44—Yarns or threads characterised by the purpose for which they are designed
- D02G3/448—Yarns or threads for use in medical applications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4266—Natural fibres not provided for in group D04H1/425
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2211/00—Protein-based fibres, e.g. animal fibres
- D10B2211/01—Natural animal fibres, e.g. keratin fibres
- D10B2211/04—Silk
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/08—Hernia repair mesh
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45358403P | 2003-03-11 | 2003-03-11 | |
| US60/453,584 | 2003-03-11 | ||
| PCT/US2004/007647 WO2004080346A2 (en) | 2003-03-11 | 2004-03-11 | Immunoneutral silk-fiber-based medical devices |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011030342A Division JP2011147790A (ja) | 2003-03-11 | 2011-02-16 | 免疫中立性の絹繊維を基礎とする医療用具 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006519664A JP2006519664A (ja) | 2006-08-31 |
| JP2006519664A5 JP2006519664A5 (enExample) | 2010-07-08 |
| JP4815554B2 true JP4815554B2 (ja) | 2011-11-16 |
Family
ID=32990790
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006507132A Expired - Fee Related JP4815554B2 (ja) | 2003-03-11 | 2004-03-11 | 免疫中立性の絹繊維を基礎とする医療用具 |
| JP2011030342A Pending JP2011147790A (ja) | 2003-03-11 | 2011-02-16 | 免疫中立性の絹繊維を基礎とする医療用具 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011030342A Pending JP2011147790A (ja) | 2003-03-11 | 2011-02-16 | 免疫中立性の絹繊維を基礎とする医療用具 |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP1601826B1 (enExample) |
| JP (2) | JP4815554B2 (enExample) |
| AT (1) | ATE514805T1 (enExample) |
| CA (1) | CA2518509C (enExample) |
| DK (2) | DK1601826T3 (enExample) |
| ES (3) | ES2424313T3 (enExample) |
| PL (2) | PL2426241T3 (enExample) |
| PT (3) | PT2426241E (enExample) |
| WO (1) | WO2004080346A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110009960A1 (en) * | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
| US6902932B2 (en) | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
| WO2006113642A1 (en) * | 2005-04-18 | 2006-10-26 | Duke University | Three-dimensional fiber scaffolds for tissue engineering |
| CN100382772C (zh) * | 2005-09-28 | 2008-04-23 | 南通大学 | 含蚕丝丝素的医用神经移植物的制备方法 |
| JP4541336B2 (ja) * | 2006-09-25 | 2010-09-08 | 独立行政法人科学技術振興機構 | フィブロイン糸を使用した小動脈用人工血管 |
| US9808557B2 (en) | 2007-08-10 | 2017-11-07 | Trustees Of Tufts College | Tubular silk compositions and methods of use thereof |
| EP2291143B1 (en) | 2008-05-16 | 2020-07-08 | Mimedx, Inc. | Medical constructs of twisted lengths of collagen fibers and methods of making same |
| JP5392744B2 (ja) * | 2008-05-23 | 2014-01-22 | 国立大学法人東京農工大学 | 人工血管及びその製造方法 |
| KR100937736B1 (ko) * | 2008-09-23 | 2010-01-21 | 동국대학교 산학협력단 | 유도 조직 재생을 위한 다공성 지지체 및 그의 제조방법 |
| US9308070B2 (en) | 2008-12-15 | 2016-04-12 | Allergan, Inc. | Pliable silk medical device |
| US9326840B2 (en) | 2008-12-15 | 2016-05-03 | Allergan, Inc. | Prosthetic device and method of manufacturing the same |
| US9757132B2 (en) | 2010-03-24 | 2017-09-12 | Biorez, Inc. | Mechanically competent scaffold for rotator cuff and tendon augmentation |
| CA2832795C (en) | 2010-04-12 | 2018-01-09 | Tufts University | Silk electronic components and the method for fabricating the same |
| AP2013006698A0 (en) * | 2010-07-05 | 2013-01-31 | Achira Labs Pvt Ltd | Methods of making a diagnostic device by interweaving hydrophobic and hydrophilic fibers, and diagnostic device therefrom |
| CN102091349B (zh) * | 2011-01-27 | 2013-06-19 | 苏州大学 | 一种高强度生物支架材料及其制备方法 |
| JP5062867B2 (ja) * | 2011-02-18 | 2012-10-31 | 福井経編興業株式会社 | 人工血管用ダブルラッシェル編地管とその製造方法 |
| JP5783794B2 (ja) * | 2011-05-19 | 2015-09-24 | カジナイロン株式会社 | 人工血管や人工臓器等の医療用基材の絹糸の製造方法 |
| US9925301B2 (en) | 2012-04-06 | 2018-03-27 | Trustees Of Tufts College | Methods of producing and using silk microfibers |
| US20150164117A1 (en) * | 2012-07-13 | 2015-06-18 | Tufts University | Encapsulation of fragrance and/or flavors in silk fibroin biomaterials |
| US10035920B2 (en) | 2012-11-27 | 2018-07-31 | Tufts University | Biopolymer-based inks and use thereof |
| AU2013358983A1 (en) * | 2012-12-14 | 2015-07-02 | Allergan, Inc. | Silk medical device |
| US9433489B2 (en) | 2013-03-12 | 2016-09-06 | Soft Tissue Regeneration, Inc. | Absorbable synthetic braided matrix for breast reconstruction and hernia repair |
| US20150056261A1 (en) * | 2013-08-22 | 2015-02-26 | Allergan, Inc. | Silk medical devices |
| WO2015048527A1 (en) | 2013-09-27 | 2015-04-02 | Tufts University | Optically transparent silk hydrogels |
| US10925999B2 (en) | 2013-10-08 | 2021-02-23 | Trustees Of Tufts College | Tunable covalently crosslinked hydrogels and methods of making the same |
| WO2015070108A1 (en) | 2013-11-08 | 2015-05-14 | Tufts University | Peptide-based nanofibrillar materials |
| KR101582202B1 (ko) * | 2014-11-05 | 2016-01-05 | 대한민국 | 누에고치를 이용한 혈관용 패치 및 이의 제조방법 |
| ES2915384T3 (es) | 2015-03-12 | 2022-06-22 | Univ Tufts | Materiales de seda con memoria de forma |
| CN107407018B (zh) * | 2015-03-20 | 2018-10-19 | 拉尔赛菲股份公司 | 用于制造基于丝绸的织物的方法及该织物的用途 |
| US10314696B2 (en) | 2015-04-09 | 2019-06-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valves having fiber reinforced leaflets |
| US10716671B2 (en) * | 2015-07-02 | 2020-07-21 | Boston Scientific Scimed, Inc. | Prosthetic heart valve composed of composite fibers |
| WO2017019841A1 (en) | 2015-07-28 | 2017-02-02 | Trustees Of Tufts College | Polypeptide monoliths |
| WO2017123383A2 (en) | 2015-12-17 | 2017-07-20 | Trustees Of Tufts College | Silk-fibroin hydrogels, methods of forming, and uses thereof |
| CN105603622A (zh) * | 2015-12-28 | 2016-05-25 | 宝鸡金健数码针纺有限责任公司 | 一种中药针织面料的生产方法 |
| WO2017165889A2 (en) * | 2016-03-25 | 2017-09-28 | Biorez, Inc. | Complex braided scaffolds for improved tissue regeneration |
| US10368982B2 (en) | 2016-05-19 | 2019-08-06 | Boston Scientific Scimed, Inc. | Prosthetic valves, valve leaflets and related methods |
| WO2017204563A1 (ko) * | 2016-05-24 | 2017-11-30 | 주식회사 아모라이프사이언스 | 세포배양 지지체용 원사, 이를 포함하는 세포배양 지지체용 원단 |
| KR101856575B1 (ko) * | 2016-05-25 | 2018-06-19 | 주식회사 아모그린텍 | 세포배양 지지체용 원사 및 이를 포함하는 원단 |
| US11248313B2 (en) | 2016-08-01 | 2022-02-15 | Trustees Of Tufts College | Biomimetic mechanical tension driven fabrication of nanofibrillar architecture |
| EP3615097A1 (en) | 2017-04-25 | 2020-03-04 | Boston Scientific Scimed, Inc. | Biocompatible polyisobutylene-fiber composite materials and methods |
| US11992686B2 (en) | 2018-03-16 | 2024-05-28 | The Regents Of The University Of California | Flexible spinal cord stimulators for pain and trauma management through neuromodulation |
| US12245935B2 (en) | 2019-11-26 | 2025-03-11 | Boston Scientific Limited | Composite web-polymer heart valve |
| WO2022147483A2 (en) * | 2020-12-31 | 2022-07-07 | Trustees Of Tufts College | Silk-based articles having decreased water uptake and improved mechanical properties, and methods of making and using the same |
| DE102023205151A1 (de) * | 2023-06-01 | 2024-12-05 | Volkswagen Aktiengesellschaft | Biomaterial umfassend bakterielle Cellulosefasern |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05228204A (ja) * | 1992-02-19 | 1993-09-07 | Pola Chem Ind Inc | 創傷被覆材及びその製造方法 |
| JPH0931798A (ja) * | 1995-07-07 | 1997-02-04 | Toru Takada | シルク・ビロード布地又は編地とその製造方法 |
| JPH11217775A (ja) * | 1996-02-23 | 1999-08-10 | Kanehisa:Kk | 先染絹生糸を用いる織編物の製造方法及びそれによって製造された織編物 |
| JP2003500162A (ja) * | 1999-05-27 | 2003-01-07 | スミス アンド ネフュー ピーエルシー | 結合組織再構成用移植片 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE367138A (enExample) * | 1930-02-03 | |||
| US4141207A (en) * | 1977-09-02 | 1979-02-27 | Shigesaburo Mizushima | Process for producing curl shrunk silk yarn |
| US5245012A (en) | 1990-04-19 | 1993-09-14 | The United States Of America As Represented By The Secretary Of The Army | Method to achieve solubilization of spider silk proteins |
| US5252285A (en) | 1992-01-27 | 1993-10-12 | E. I. Du Pont De Nemours And Company | Process for making silk fibroin fibers |
| IL123398A0 (en) | 1995-08-22 | 1998-09-24 | Agricola Tech Inc | Cloning methods for high strength spider silk proteins |
| JP2997758B2 (ja) * | 1996-01-23 | 2000-01-11 | 農林水産省蚕糸・昆虫農業技術研究所長 | 創傷被覆材 |
| US6175053B1 (en) | 1997-06-18 | 2001-01-16 | Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forrestry And Fisheries | Wound dressing material containing silk fibroin and sericin as main component and method for preparing same |
| IT1316885B1 (it) * | 2000-10-02 | 2003-05-13 | Consorzio Per Gli Studi Uni | Procedimento per la preparazione di un tessuto non tessuto in fibroinadi seta. |
-
2004
- 2004-03-11 EP EP04719844A patent/EP1601826B1/en not_active Expired - Lifetime
- 2004-03-11 ES ES11171347T patent/ES2424313T3/es not_active Expired - Lifetime
- 2004-03-11 ES ES04719844T patent/ES2368843T3/es not_active Expired - Lifetime
- 2004-03-11 PT PT111908455T patent/PT2426241E/pt unknown
- 2004-03-11 JP JP2006507132A patent/JP4815554B2/ja not_active Expired - Fee Related
- 2004-03-11 PT PT111713475T patent/PT2374919E/pt unknown
- 2004-03-11 PL PL11190845T patent/PL2426241T3/pl unknown
- 2004-03-11 CA CA2518509A patent/CA2518509C/en not_active Expired - Fee Related
- 2004-03-11 EP EP11171347.5A patent/EP2374919B9/en not_active Expired - Lifetime
- 2004-03-11 EP EP11190845.5A patent/EP2426241B9/en not_active Expired - Lifetime
- 2004-03-11 PT PT04719844T patent/PT1601826E/pt unknown
- 2004-03-11 DK DK04719844.5T patent/DK1601826T3/da active
- 2004-03-11 PL PL11171347T patent/PL2374919T3/pl unknown
- 2004-03-11 ES ES11190845T patent/ES2425101T3/es not_active Expired - Lifetime
- 2004-03-11 DK DK11171347.5T patent/DK2374919T3/da active
- 2004-03-11 AT AT04719844T patent/ATE514805T1/de active
- 2004-03-11 WO PCT/US2004/007647 patent/WO2004080346A2/en not_active Ceased
-
2011
- 2011-02-16 JP JP2011030342A patent/JP2011147790A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05228204A (ja) * | 1992-02-19 | 1993-09-07 | Pola Chem Ind Inc | 創傷被覆材及びその製造方法 |
| JPH0931798A (ja) * | 1995-07-07 | 1997-02-04 | Toru Takada | シルク・ビロード布地又は編地とその製造方法 |
| JPH11217775A (ja) * | 1996-02-23 | 1999-08-10 | Kanehisa:Kk | 先染絹生糸を用いる織編物の製造方法及びそれによって製造された織編物 |
| JP2003500162A (ja) * | 1999-05-27 | 2003-01-07 | スミス アンド ネフュー ピーエルシー | 結合組織再構成用移植片 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1601826B1 (en) | 2011-06-29 |
| PT2426241E (pt) | 2013-08-30 |
| EP2426241B9 (en) | 2013-10-23 |
| EP1601826A2 (en) | 2005-12-07 |
| CA2518509A1 (en) | 2004-09-23 |
| ES2368843T3 (es) | 2011-11-22 |
| WO2004080346A9 (en) | 2005-02-17 |
| EP2374919B1 (en) | 2013-05-08 |
| PL2374919T3 (pl) | 2013-10-31 |
| EP2426241B1 (en) | 2013-05-22 |
| WO2004080346A2 (en) | 2004-09-23 |
| PT2374919E (pt) | 2013-08-26 |
| EP2374919A1 (en) | 2011-10-12 |
| DK2374919T3 (da) | 2013-08-05 |
| DK1601826T3 (da) | 2011-10-24 |
| CA2518509C (en) | 2014-04-29 |
| ES2424313T3 (es) | 2013-10-01 |
| JP2011147790A (ja) | 2011-08-04 |
| EP2374919B9 (en) | 2013-10-23 |
| WO2004080346A3 (en) | 2004-12-09 |
| PL2426241T3 (pl) | 2013-10-31 |
| JP2006519664A (ja) | 2006-08-31 |
| EP1601826A4 (en) | 2010-01-06 |
| EP2426241A1 (en) | 2012-03-07 |
| ATE514805T1 (de) | 2011-07-15 |
| PT1601826E (pt) | 2011-10-11 |
| ES2425101T3 (es) | 2013-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4815554B2 (ja) | 免疫中立性の絹繊維を基礎とする医療用具 | |
| US8685426B2 (en) | Methods for making biocompatible, implantable, substantially sericin free silk fabric | |
| AU2011264880B2 (en) | A prosthetic fabric structure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070302 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070302 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100518 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100816 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101110 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101117 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110216 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110511 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110606 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110615 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20110708 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110708 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110805 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140909 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |